Rolf F Kletzien, PhD

default.jpg
  • Research Professor, Department of Biomedical Sciences
    • Primary Address
    • Business
    • Metabolic Solution Development Company (MSDC)
    • 4th Floor
    • 161 E. Michigan Avenue
    • Kalamazoo, MI, United States 49007

Biography

Biography

Rolf Kletzien, PhD, is co-founder, senior vice president-research, and a board member for Metabolic Solutions Development Company (MSDC) in Kalamazoo, Michigan, a drug discovery and development company investigating new molecular targets and developing novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes.

Dr. Kletzien is a graduate of University of Wisconsin in Madison, Wisconsin. He also earned his doctorate in oncology from University of Wisconsin.

Prior to founding MSDC, Dr. Kletzien worked for The Upjohn Company, Pharmacia & Upjohn, Pharmacia Corporation, and Pfizer Corporation most recently, where he served as vice president of genomics & biotechnology. He has four patents to his name and has extensive research grant experience. He also has a considerable publication list, with more than 70 articles he has contributed to.

Education

  • PhD 1974, Oncology, University of Wisconsin-Madison
  • PhD 1974, Oncology, University of Wisconsin-Madison
  • BS 1970, Biochemistry, University of Wisconsin-Madison
  • BS 1970, Biochemistry, University of Wisconsin-Madison